Shares of biotechnology company Amgen Inc. dropped in Thursday premarket trading after the company said the Securities and Exchange Commission is conducting an informal inquiry regarding a study involving one of its drugs.
From: biz.yahoo.com
Premarket Movers: Amgen Down
Posted by Ruslan Abuzant at 7:24 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment